Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.15

€2.15

-3.810%
-0.084
-3.810%
-

-

 
13.03.26 / Tradegate WKN: A2AC4K / Name: Editas Medicine / Stock / Biotechnology & Medical Research / Small Cap /

Editas Medicine Inc Stock

Heavy losses for Editas Medicine Inc today as the stock fell by -€0.084 (-3.810%).
Our community identified positive and negative aspects for Editas Medicine Inc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Editas Medicine Inc stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.

Pros and Cons of Editas Medicine Inc in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Editas Medicine Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Editas Medicine Inc -3.810% 24.515% 44.702% 70.918% 22.704% -72.641% -94.445%
Heron Therapeutics Inc. -5.000% -7.083% -20.452% -64.977% -30.521% -65.330% -94.528%
Evolus Inc 0.000% -8.936% 18.889% -63.729% -21.468% -45.823% -56.442%
Sangamo Therapeutics Inc. -5.730% 2.026% 1.590% -62.380% -5.003% -84.119% -96.551%